Publications for Lovisa Farnebo
Co-author map based on ISI articles 2007-
|Lovisa Farnebo, Katharina Tiefenböck, Anna Ansell, Lena Thunell, Stina Garvin and Karin Roberg|
Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients
International Journal of Cancer, 2013, 133(8), 1994-2003.
Web of Science® Times Cited: 1
|Lovisa Farnebo, Fredrik Jerhammar, Rebecca Ceder, Roland C Grafström, Linda Vainikka, Lena Thunell, Reidar Grénman, Ann-Charlotte Johansson and Karin Roberg|
Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines
Journal of Oral Pathology & Medicine, 2011, 40(10), 739-746.
Web of Science® Times Cited: 3
|Lovisa Farnebo, Adam Jedlinski, Anna Ansell, Linda Vainikka, Lena Thunell, Reidar Grenman, Ann-Charlotte Johansson and Karin Roberg|
Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines
International Journal of Molecular Medicine, 2009, 24(4), 549-556.
Web of Science® Times Cited: 12
|Anna Ansell, Lovisa Farnebo, Reidar Grenman, Karin Roberg and Lena Thunell|
Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer
Oral Oncology, 2009, 45(1), 23-29.
Web of Science® Times Cited: 11
|Karin Roberg, Rebecca Ceder, Lovisa Farnebo, Lena Norberg-Spaak and Roland Grafström|
Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture
Differentiation, 2008, 76(8), 868-880.
Web of Science® Times Cited: 6